FDA Inspection 1103220 — Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy
The FDA completed an inspection of Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy on September 27, 2019 in Roselle, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Roselle, IL (United States)